Sartorius Stedim Biotech Shares Surge 4.5%, Breaking Through Resistance at €183.70
The French bioproduction equipment specialist significantly accelerates during the session, reaching the top of the SBF 120 index. The stock continues the rebound that started the previous day and crosses a technical threshold that has been watched for several weeks.
A Resistance Breakthrough Propels the Stock Among the Top Gainers of the SBF 120
Sartorius Stedim Biotech shares gain 4.68% to €188.00, up from €179.60 the previous day. The stock is among the top gainers in the SBF 120, while the index is nearly stable (+0.07%). Today's movement brings the performance to 5.8% over one month and 11.3% over three months, although the annual performance remains negative at -6.2%. The session is marked by a clear breakthrough: the stock has broken its resistance at €183.70 and remains above it, a threshold that was already identified in mid-June during the test of the same area.
A Rebound That Recalibrates the Stock Above Its Three Moving Averages
The price moves back above its three reference moving averages, with a gap of 7.7% over the MM20 (€174.52), 9.7% over the MM50 (€171.34), and 1.5% over the MM200 (€185.16). The RSI at 56 remains in the neutral zone, which leaves room before entering overbought territory. The MACD, with a line at 1.41 above its signal at 1.03, confirms the recovery in dynamics observed since mid-May, after the documented drop in mid-June.
Based on the consensus of the analysts surveyed, the stock is trading at about 37 times the earnings expected this year and 31 times those of 2027. The next identified resistance is at €223, while the major support is at €161.90.
